U.S. Bioscience, Inc.
13Patents
0Active
13Granted
33Portfolio score
Filing activity: Jul 3, 1989 → May 18, 1998
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4957481A | Photodynamic therapeutic technique | Human Necessities | 126 | Expired |
| US5591731A | Crystalline amifostine compositions | Chemistry; Metallurgy | 72 | Expired |
| US5424471A | Crystalline amifostine compositions and methods of the preparation and use of same | Chemistry; Metallurgy | 20 | Expired |
| US5994409A | Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds | Human Necessities | 17 | Expired |
| US5846958A | Methods of using aminothiols to promote hematopoietic progenitor cell growth | Human Necessities | 15 | Expired |
| US6017922A | Thermally stable trimetrexates and processes for producing the same | Human Necessities | 14 | Expired |
| US5491135A | Compositions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6051563A | Methods for the administration of amifostine and related compounds | Human Necessities | 6 | Expired |
| US5292497A | Method of reducing chemotherapy toxicity using (methylaminopropylamino)propyl dihydrogen phosphorothioate | Human Necessities | 6 | Expired |
| US5804571A | Method for protection from AZT side effects and toxicity | Human Necessities | 5 | Expired |
| US6017921A | Crystalline trimetrexate salts and the process for making the same | Human Necessities | 5 | Expired |
| US5824664A | Suppression of HIV expression by organic thiophosphate | Human Necessities | 5 | Expired |
| US5906984A | Methods of using aminothiols to promote hematopoietic progenitor cell growth | Human Necessities | 3 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.